Royalty Pharma plc Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 1,517.86M2,461.42M1,701.95M1,241.20M230.06M1,700.09M1,330.81M
Gains from Investment Securities 39.40M27.04M42.33M34.85M39.14M18.82M18.00M
Cash from Operations 1,618.32M1,667.24M2,034.63M2,017.54M2,143.98M2,987.80M2,768.99M
Investing Activities
Capital Expenditures 269.59M1,721.29M2,182.25M2,191.50M1,741.64M2,115.52M2,505.70M
Divestments 15.08M0.52M43.88M23.64M
Change in Acquisitions & Divestments 750.00M725.07M815.44M1,597.85M792.34M24.39M19.79M
Cash from Investing Activities 303.42M-2153.62M-2759.32M-1870.28M-1029.42M-2072.79M-2678.11M
Financing Activities
Other financing activities 2.05M46.72M13.05M1.35M1.60M12.62M
Cash from Financing Activities -1379.10M-1191.63M1,487.17M385.11M-944.86M-2148.75M361.14M
Dividend Payments
Dividends Paid - Common 268.69M154.08M113.48M133.43M144.12M119.53M125.16M
Additional items
Change in Cash 542.64M-1678.01M762.48M532.37M169.70M-1233.74M452.02M
Beginning Cash Balance -542.64M1,640.51M246.20M1,008.68M1,541.05M1,710.75M477.01M
Free Cash Flow 1,348.72M-54.05M-147.62M-173.97M402.34M872.28M263.29M
Net Cash Flow 542.64M-1678.01M762.48M532.37M169.70M-1233.74M452.02M